Skip to main content
. Author manuscript; available in PMC: 2013 May 2.
Published in final edited form as: Vaccine. 2012 Mar 13;30(21):3180–3187. doi: 10.1016/j.vaccine.2012.03.003

Table 2.

AG129 analytes associated with inflammation or tissue damage undergoing 4-fold or greater change in concentration as a result of 17D-204 infection

Pro-inflammatory Serum Liver Brain


CD40L CD40 Ligand
GMCSF Granulocyte-Macrophage Colony-Stimulating Factor
KC/GRO Growth-Regulated Alpha Protein
IFNγ Interferon gamma
IP-10 IFNγ Induced Protein 10
IL-1α Interleukin-1 alpha
IL-1β Interleukin-1 beta
Il-2 Interleukin-2
IL-6 Interleukin-6
IL-11 Interleukin-11
IL-12p70 Interleukin-12 subunit p70
MIP-1β CCL-4/Macrophage Inflammatory Protein-1 beta
MIP-1γ CCL-9/Macrophage Inflammatory Protein-1 gamma
MIP-2 CXCL-2/Macrophage Inflammatory Protein-2
MIP-3β Macrophage Inflammatory Protein-3 beta
MCP-1 CCL-2/Macrophage Chemotactic Protein-1
MCP-3 CCL-7/Macrophage Chemotactic Protein-3
MCP-5 CCL-12/Macrophage Chemotactic Protein-5
OSM Oncostatin-M
RANTES CCL-5/Regulated upon Activation,
Normal T-cell Expressed, and Secreted
TNFα Tumor Necrosis Factor alpha
Anti-inflammatory
IL-4 Interleukin-4
IL-10 Interleukin-10
Tissue Damage
Fibrinogen Fibrinogen
IL-7 Interleukin-7
MMP-9 Matrix Metalloproteinase 9
Myoglobin Myoglobin
MPO Myeloperoxidase
SGOT AST/Serum Glutamic Oxaloacetic Transaminase
TPO Thrombopoietin